Skip to NavigationSkip to content

News

A new report published by the life science incubator and business collective BioCity has painted a promising picture of UK start-up prosperity –...
Eli Lilly is poised to boost its manufacturing capacity with the investment of $400 million at its Lilly Technology Center campus in Indianapolis,...
MSD’s top-selling immunotherapy Keytruda (pembrolizumab) has secured another approval from the European Commission, this time in the first-line...
Allergan has revealed positive Phase 3 data on its oral calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant, illustrating the...
Genmab’s Darzalex (daratumumab) has secured approval from the European Commission and is now authorised in Europe for the treatment of newly...
MSD’s Keytruda (pembrolizumab) overtook Bristol-Myers Squibb’s (BMS) blockbuster drug Opdivo (nivolumab) in total sales in the third quarter of...
As revealed in correspondence with the California Employment Development Department, Amgen plans to axe 172 staff positions across the US,...
MSD and Bayer have made it known that their jointly-developed soluble guanylate cyclase (sGC) stimulator vericiguat met its primary endpoint as a...
Vertex and CRISPR Therapeutics have unveiled the first interim Phase 1/2 data demonstrating the safety and efficacy of the investigational CRISPR/...
Through the deal, Alkermes intends to push “Investigational New Drug (IND)-enabling activities” for Rodin’s preclinical products in the treatment...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches